Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Sleep Deprivation
Intervention: Other: Sleep Enhancement Program (SEP)
Sponsors: University of Arizona; Arizona Biomedical Research Commission (ABRC)
Not yet recruiting - verified March 2010
Conditions: Pneumococcal Nasopharyngeal Colonization; Invasive Pneumococcal Disease
Intervention:
Sponsors: Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH); Centers for Disease Control and Prevention
Recruiting - verified March 2010
Conditions: Mild Cognitive Impairment; Alzheimer's Disease
Intervention:
Sponsors: Alzheimer's Disease Cooperative Study (ADCS); National Institute on Aging (NIA); National Institutes of Health (NIH)
Not yet recruiting - verified March 2010
Conditions: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Polyneuropathy
Interventions: Drug: SB-509; Other: Saline
Sponsors: Sangamo Biosciences; Juvenile Diabetes Research Foundation
Recruiting - verified March 2010
Condition: Breast Cancer
Intervention: Drug: letrozole
Sponsors: University of Arizona; National Cancer Institute (NCI)
Not yet recruiting - verified February 2010
Condition: Malignant Melanoma
Intervention: Device: SciBase III Electrical Impedance Spectrometer
Sponsor: SciBase AB
Not yet recruiting - verified February 2010
Condition: Training
Intervention: Device: ERCP mechanical simulator practice
Sponsors: East Bay Institute for Research and Education; University of California, Davis; University of California, Irvine Medical Center; University of Arizona Medical Center; Phoenix VA Medical Center; University of New Mexico Hospital; San Diego Naval Medical Center; Kaiser Permanente Medical Center, Los Angeles
Completed - verified March 2010
Conditions: Cocaine Dependence; Methamphetamine Dependence; Nicotine Dependence
Intervention: Other: Smoking-cessation treatment
Sponsors: University of Cincinnati; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2010
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Peripheral T-Cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Splenic Marginal Zone Lymphoma; Waldenstrom Macroglobulinemia
Interventions: Drug: everolimus; Drug: lenalidomide; Other: laboratory biomarker analysis; Genetic: polymorphism analysis; Other: immunohistochemistry staining method; Genetic: microarray analysis; Genetic: fluorescence in situ hybridization
Sponsor: Mayo Clinic
Not yet recruiting - verified February 2010
Condition: Metastatic Breast Cancer
Intervention: Drug: (will be assigned based on molecular profile and RPMA)
Sponsors: TGen Drug Development Services; SideOut Foundation
Recruiting - verified February 2010